Now Is A Good Time To Buy Bicara Therapeutics Inc (NASDAQ: BCAX)

During the last session, Bicara Therapeutics Inc (NASDAQ:BCAX)’s traded shares were 1.04 million. At the end of the trading day, the stock’s price was $9.44, reflecting an intraday loss of -0.21% or -$0.02. The 52-week high for the BCAX share is $28.09, that puts it down -197.56 from that peak though still a striking 17.37% gain since the share price plummeted to a 52-week low of $7.80. The company’s market capitalization is $514.82M, and the average intraday trading volume over the past 10 days was 1.49 million shares, and the average trade volume was 733.78K shares over the past three months.

Bicara Therapeutics Inc (NASDAQ:BCAX) trade information

Bicara Therapeutics Inc (BCAX) registered a -0.21% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -0.21% in intraday trading to $9.44, hitting a weekly high. The stock’s 5-day price performance is -35.30%, and it has moved by -36.56% in 30 days. The short interest in Bicara Therapeutics Inc (NASDAQ:BCAX) is 7.42 million shares and it means that shorts have 12.49 day(s) to cover.

The consensus price target of analysts on Wall Street is $28, which implies an increase of 66.29% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $8 and $48 respectively. As a result, BCAX is trading at a discount of -408.47% off the target high and 15.25% off the low.

BCAX Dividends

Bicara Therapeutics Inc is due to release its next quarterly earnings on 2025-May-12. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Bicara Therapeutics Inc (NASDAQ:BCAX)’s Major holders

Bicara Therapeutics Inc insiders own 11.65% of total outstanding shares while institutional holders control 89.24%, with the float percentage being 101.00%.

Also, the Mutual Funds coming in first place with the largest holdings of Bicara Therapeutics Inc (BCAX) shares are Fidelity Select Portfolios-Health Care Portfolio and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund. Data provided on Mar 31, 2025 indicates that Fidelity Select Portfolios-Health Care Portfolio owns about 700.0 shares. This amounts to just over 1.28 percent of the company’s overall shares, with a $6.61 million market value. The same data shows that the other fund manager holds slightly less at 636.55, or about 1.17% of the stock, which is worth about $6.01 million.